ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...
The Australian stock market recently experienced a solid performance, buoyed by higher gold and silver prices and a positive ...
Severe alopecia areata may be driven by broader immune activation than previously recognized, according to new research ...
Researchers have examined cellular crosstalk between the gut and liver during sepsis, helping us better understand sepsis ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, ...
GlobalData on MSN
ImmunityBio’s Anktiva shows success as combo treatment in NSCLC
Anktiva plus checkpoint inhibitor therapy demonstrated statistically significant immune restoration across two clinical ...
Data from eight participants continue to support safety and tolerability profile of tegoprubartMean eGFR increased over the measurement period, ...
Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...
Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...
Study Finds on MSN
What If Your Skin Could Warn You About Disease Before Symptoms Appear By Glowing Green?
Green means go…to the doctor In A Nutshell Scientists engineered living skin that glows green when it detects inflammation in ...
A nano-sized medicine boosts the anti-cancer immune response and eradicates tumors in mice. Researchers at Washington University School of Medicine in St. Louis, working with colleagues at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results